1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Coronary Guidewires Overview
3 Products under Development
3.1 Coronary Guidewires - Pipeline Products by Stage of Development
3.2 Coronary Guidewires - Pipeline Products by Territory
3.3 Coronary Guidewires - Pipeline Products by Regulatory Path
3.4 Coronary Guidewires - Pipeline Products by Estimated Approval Date
3.5 Coronary Guidewires - Ongoing Clinical Trials
4 Coronary Guidewires - Pipeline Products under Development by Companies
4.1 Coronary Guidewires Companies - Pipeline Products by Stage of Development
4.2 Coronary Guidewires - Pipeline Products by Stage of Development
5 Coronary Guidewires Companies and Product Overview
5.1 Abbott Vascular Inc Company Overview
5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Bioscan Technologies Inc. Company Overview
5.2.1 Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.3 Boston Scientific Corp Company Overview
5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.4 Cardiovascular Systems Inc Company Overview
5.4.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 CorMetrics LLC Company Overview
5.5.1 CorMetrics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.6 Echopoint Medical Ltd Company Overview
5.6.1 Echopoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.7 ENDOMATERIALS Company Overview
5.7.1 ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview
5.8 Georgia Institute of Technology Company Overview
5.8.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
5.9 Guided Interventions, LLC Company Overview
5.9.1 Guided Interventions, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.10 Infrared Sciences Corp Company Overview
5.10.1 Infrared Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
5.11 Koninklijke Philips NV Company Overview
5.11.1 Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview
5.12 MaRVis Technologies GmbH Company Overview
5.12.1 MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.13 Microbot Medical Ltd Company Overview
5.13.1 Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.14 MicroPort Scientific Corp Company Overview
5.14.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.15 OVALUM Ltd Company Overview
5.15.1 OVALUM Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.16 SoundBite Medical Solutions Inc Company Overview
5.16.1 SoundBite Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 St. Jude Medical LLC Company Overview
5.17.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.18 Terumo Corp Company Overview
5.18.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
5.19 Terumo Interventional Systems Company Overview
5.19.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
5.20 The Cleveland Clinic Foundation Company Overview
5.20.1 The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview
5.21 Three Rivers Cardiovascular Systems Inc Company Overview
5.21.1 Three Rivers Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 University of Illinois at Chicago Company Overview
5.22.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
5.23 Vasostar Ltd. Company Overview
5.23.1 Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview
6 Coronary Guidewires- Recent Developments
6.1 Oct 05, 2021: Merit Medical Systems to Announce Third Quarter Results on October 28, 2021
6.2 Sep 29, 2021: OpSens to Present at the Lytham Partners Fall 2021 Investor Conference
6.3 Sep 09, 2021: Merit Medical Systems to Announce First Quarter Results on April 29, 2021
6.4 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
6.5 Aug 04, 2021: Terumo Revises its Full-Year Financial Guidance for FY2021
6.6 Jul 13, 2021: AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results
6.7 Jul 09, 2021: Merit Medical Systems to Announce Second Quarter Results on July 29, 2021
6.8 Jul 02, 2021: Northern Ohio Health System agrees to pay over $21 million to resolve false claims act allegations for improper payments to referring physicians
6.9 Jun 30, 2021: B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer
6.10 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
6.11 May 14, 2021: Asahi Intecc Announces Financial Results and Presentation Materials for the 3rd Quarter of the Fiscal Year ending June 2021
6.12 May 14, 2021: Asahi Intecc announces third and fourth half of the financial statements for the June period of 2021
6.13 Mar 30, 2021: AngioDynamics Reports Fiscal 2021 Third Quarter Financial Results and Updates Guidance
6.14 Mar 29, 2021: Merit Medical Reports Results for Quarter Ended March 31, 2021
6.15 Mar 22, 2021: OpSens to Present at Lytham Partners Spring 2021 Investor Conference
6.16 Mar 22, 2021: Terumo and Allied Telesis jointly develop a smooth operating environment for infusion systems
6.17 Mar 01, 2021: AngioDynamics to Present at the Barclays Virtual Global Healthcare Conference
6.18 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
6.19 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.20 Feb 12, 2021: Merit Medical Systems to Announce Fourth Quarter and Year End 2020 Results on February 24, 2021
6.21 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
6.22 Feb 10, 2021: Merit Medical to Present at 2021 SVB Leerink Global Healthcare Conference
6.23 Feb 04, 2021: Terumo announce Financial Statements
6.24 Jan 07, 2021: Merit Medical to Participate in Two Upcoming Investor Conferences
6.25 Jan 06, 2021: OpSens to Host First Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, January 13, 2021
6.26 Jan 06, 2021: Abbott Hosts Conference Call for Fourth-Quarter Earnings
6.27 Jan 04, 2021: AngioDynamics to Present at the J.P. Morgan Virtual Healthcare Conference
6.28 Dec 28, 2020: Cook Medical launches a new Customer Portal to enhance customer experience
6.29 Oct 23, 2020: Mentice receives order of total SEK 7.1 million from ABBOTT
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer